9 October 11:30-13:00Umeå university, Biology Building, floor 2, room BIO.D.244​

Academia is the birthplace of groundbreaking knowledge — but too often, that knowledge remains confined to publications and conferences. The journey from scientific insight to tangible innovation in healthcare is rarely straightforward, and many researchers find the path unclear.​

This seminar, with Dr. Fabio Iachetti, MD, and Adj. Prof. Karl Andersson, is designed to illuminate that path.​

Join us as we explore how researchers can identify opportunities to translate their work into practical solutions that address real needs in healthcare. 

We’ll also dive into the first actionable steps toward transforming promising ideas into validated products and services — bridging the gap between research and impact.​

Whether you're curious about innovation, considering commercialization, or already on the path, this session will provide valuable insights, inspiration, and practical tools to help you move forward.​

Note: Salad is included, for free, for all participants. 

Registration deadline: October 7. 

Speakers

Dr. Fabio Iachetti, MD
Industry Medical Doctor | Digital Health Expert | Medical Trainer

Fabio is a board-certified physician and senior leader in Medical Affairs, pairing 20 years of clinical expertise with digital health and IT savvy. He has steered 50+ trials and 20+ launches (including a China roll-out touching 1.5 M HCPs), led 45 global symposia across 10+ disease areas, and co-created the Allergen Encyclopedia, which draws 300k HCPs annually.

Read more

Adj Prof Karl Andersson
Senior Advisor | Scientific Entrepreneur | Systems Thinker | PhD Bioinformatics

​Karl is an experienced cross-disciplinary innovator working at the intersection of biomedical technology, diagnostics, and data-driven healthcare. With a background in engineering physics and medical sciences, he has co-founded multiple ventures in the life sciences sector and advised companies on medical device strategy, software compliance, and intellectual property.

Read more

State aid 

Participation fee: This event is sponsored by Umeå Biotech Incubator (UBI) with support from the European Union. There is no actual fee for participating. For delegates from the industry, state-aid/de-minimis will be accounted for corresponding to 300 SEK per person.

State aid & de-minimis: Umeå Biotech Incubator is obliged to account for activities they arrange, and support they provide, directed to specific companies or a group of companies where the receiving companies do not pay market price for the participation. The value of this support is accounted for as state-aid. 

Small amounts of State aid (‘de minimis’ aid) are exempted from State aid control, as they are deemed to have no impact on competition and trade in the internal market of the European Union (EU). 

De minimis aid indeed refers to small amounts of State aid to undertakings (companies) that do not have to be notified to the European Commission by the EU Member States. The maximum amount is € 300,000 for each undertaking over 3 years.

De minimis can also be granted to large companies that are not entitled to larger sums of state-aid under Article 22. Read more on state-aid and de-minimis here:

© MapTiler © OpenStreetMap contributors

Organized by